A two-page B5-sized conference flyer designed to promote Erelzi at an ARA (Australian Rheumatology Association) conference. The artwork highlights Erelzi as a biosimilar etanercept treatment used in inflammatory and autoimmune conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

Leadtime:

• Production: 3-4 working days
• Delivery 3-6 working days